Innate Pharma SA Vs. Aritzia Industry Stock Comparison

Sell

16

IPHA
Innate Pharma SA

Last Price:

1.64

Seasonality Move:

11.17%

Sell

40

ATZAF
Aritzia

Last Price:

32.69

Seasonality Move:

14.48%

Sell

16

Innate Pharma SA (IPHA) is a Sell

Is Innate Pharma SA a Buy, Sell or Hold?

The current Innate Pharma SA [IPHA] share price is $1.68. The Score for IPHA is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
IPHA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
This Score is currently showing an extreme reading that indicates risk could be especially high.

Sell

40

Aritzia (ATZAF) is a Sell

Is Aritzia a Buy, Sell or Hold?

The current Aritzia [ATZAF] share price is $33.13. The Score for ATZAF is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
ATZAF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

IPHA Stock Price Chart

What is Innate Pharma SA's stock price today?

The Innate Pharma SA share price today is $1.68
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IPHA is experiencing selling pressure, which indicates risk of future bearish movement.

ATZAF Stock Price Chart

What is Aritzia's stock price today?

The Aritzia share price today is $33.13
The current trend is relatively stagnant and ATZAF is experiencing slight buying pressure.

IPHA Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.07	Sell
Relative Strength Index (14 RSI):	38.57	Sell
Chaikin Money Flow:	-3758	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(1.79 - 2.03)	Sell
Bollinger Bands (100):	(1.96 - 2.28)	Sell

ATZAF Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.72	Sell
Relative Strength Index (14 RSI):	51.58	Buy
Chaikin Money Flow:	485	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(30.46 - 34.6)	Buy
Bollinger Bands (100):	(30.22 - 35.52)	Buy

IPHA Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	1.85	Sell
20-day SMA:	1.87	Sell
50-day SMA:	2.07	Sell
200-day SMA:	2.34	Sell
8-day EMA:	1.83	Sell
20-day EMA:	1.89	Sell
50-day EMA:	2.01	Sell
200-day EMA:	2.29	Sell

ATZAF Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	31.85	Buy
20-day SMA:	31.82	Buy
50-day SMA:	34.06	Sell
200-day SMA:	29.54	Buy
8-day EMA:	31.74	Buy
20-day EMA:	32.3	Buy
50-day EMA:	33.02	Buy
200-day EMA:	30	Buy

Innate Pharma SA Earnings Growth & IPHA Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.52 per share, and a decrease next year of $0.00 per share.

Aritzia Earnings Growth & ATZAF Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.68 per share, and an increase next year of $0.57 per share.

Innate Pharma SA Technical Analysis

	Oct 31	Nov 1	Nov 4	Nov 5	Nov 6	Nov 7	Nov 8	Nov 11	Nov 12	Nov 13
	Oct		Nov
	31	01	04	05	06	07	08	11	12	13
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Aritzia Technical Analysis

	Oct 31	Nov 1	Nov 4	Nov 5	Nov 6	Nov 7	Nov 8	Nov 11	Nov 12	Nov 13
	Oct		Nov
	31	01	04	05	06	07	08	11	12	13
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):